XML 23 R50.htm IDEA: XBRL DOCUMENT v2.4.0.8
Investments in and Advances to Unconsolidated Joint Ventures (Details) (USD $)
3 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Dec. 31, 2013
Company owned interests in entities, accounted under equity method:      
Investments in and advances to unconsolidated joint ventures $ 193,930,000   $ 196,576,000
Investment reported in liabilities (1,087,000)    
Summarized combined financial information for unconsolidated joint ventures:      
Real estate, net 3,644,045,000   3,662,450,000
Goodwill and other assets, net 5,414,544,000   5,384,553,000
Total assets 9,058,589,000   9,047,003,000
Capital lease obligations and mortgage debt 6,736,980,000   6,768,815,000
Accounts payable 1,083,690,000   1,045,260,000
Other partners' capital 1,102,974,000   1,098,228,000
HCP's capital 134,945,000   134,700,000
Total liabilities and partners' capital 9,058,589,000   9,047,003,000
Combined basis difference 57,000,000    
Total revenues 1,079,891,000 1,093,374,000  
Net income 7,996,000 10,584,000  
HCP's share of earnings 14,528,000 14,801,000  
Fees earned by HCP 449,000 443,000  
Distributions received by HCP 3,202,000 1,371,000  
HCR ManorCare | Post-acute/skilled
     
Company owned interests in entities, accounted under equity method:      
Investments in and advances to unconsolidated joint ventures 82,311,000    
Investment ownership percentage 9.50%    
Recharacterized DFL income to equity income 15,600,000 15,900,000  
HCP Ventures III, LLC | Medical office
     
Company owned interests in entities, accounted under equity method:      
Investments in and advances to unconsolidated joint ventures 7,065,000    
Investment ownership percentage 30.00%    
HCP Ventures IV, LLC | Hospital and medical office segments
     
Company owned interests in entities, accounted under equity method:      
Investments in and advances to unconsolidated joint ventures 29,074,000    
Investment ownership percentage 20.00%    
HCP Life Science | Life science
     
Company owned interests in entities, accounted under equity method:      
Investments in and advances to unconsolidated joint ventures 68,798,000    
Number of unconsolidated joint ventures 3    
HCP Life Science | Life science | Minimum
     
Company owned interests in entities, accounted under equity method:      
Investment ownership percentage 50.00%    
HCP Life Science | Life science | Maximum
     
Company owned interests in entities, accounted under equity method:      
Investment ownership percentage 63.00%    
Torrey Pines Science Center, LP | Life science
     
Company owned interests in entities, accounted under equity method:      
Investment ownership percentage 50.00%    
Britannia Biotech Gateway, LP | Life science
     
Company owned interests in entities, accounted under equity method:      
Investment ownership percentage 55.00%    
LASDK, LP | Life science
     
Company owned interests in entities, accounted under equity method:      
Investment ownership percentage 63.00%    
Suburban Properties, LLC | Medical office
     
Company owned interests in entities, accounted under equity method:      
Investments in and advances to unconsolidated joint ventures 6,180,000    
Investment ownership percentage 67.00%    
Advances to unconsolidated joint ventures, net
     
Company owned interests in entities, accounted under equity method:      
Investments in and advances to unconsolidated joint ventures 502,000    
Edgewood Assisted Living Center, LLC | Senior housing
     
Company owned interests in entities, accounted under equity method:      
Investment reported in liabilities (431,000)    
Seminole Shores Living Center, LLC | Senior housing
     
Company owned interests in entities, accounted under equity method:      
Investment reported in liabilities (656,000)    
Senior housing partnership | Senior housing
     
Company owned interests in entities, accounted under equity method:      
Investments in and advances to unconsolidated joint ventures $ 0    
Investment ownership percentage 72.00%